Surgical Stapler Market (Technology, Type, Product, Application, End User) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The surgical stapler market size was reached at USD 5.2 billion in 2021 and is exhibiting around USD 9.3 billion by 2030 with a CAGR of 7.49% from 2022 to 2030.

Surgical Stapler Market Size 2021 to 2030

Report Highlights

  • By technology, the manual segment accounted market share of over 58% in 2021.
  • By type, the reusable segment accounted 61% market share in 2021.
  • By end user, hospitals segment accounted highest revenue share of 67.7% in 2021.
  • North America region hit highest market share 40.8% in 2021.

Growing number of surgical procedures, increasing usage of surgical stapling devices in bariatric surgeries, and rising preference of minimally invasive procedures are some of the primary factors to boost the growth of surgical stapling devices market in future.

In addition, there has been an increased demand for surgical stapling devices in various surgeries such as laparoscopic procedures, bariatric procedures, endoscopic procedures etc. Due to growing rate of chronic conditions such as obesity or even in sports related injuries/ arthritis surgeries, the demand and usage of stapling devices have been utilized in most of the cases.

Also, the rise in laparoscopic procedures elected by the patients is expected to drive the global surgical stapling devices market over the forecast period. The growing trend of laparoscopic surgeries is due to smaller incision, lower cost associated with the surgery and lesser hospital stays.

Moreover, manufacturers of surgical stapling devices are continuously investing in research and development activities to design, develop and launch technologically advanced products and to improve their current product portfolios so as to maintain their share in the market.

The sudden outbreak of COVID-19 has had a severe impact on the surgical staple industry due to the lockdown measures across the world that have resulted in decreased public mobility and a sudden halt on surgical procedures that are non-immediate and are being postponed to decrease the burden on healthcare infrastructure. According to the article titled ' Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to infrom surgical recovery plans' published in the British Journal of Surgery in May 2020, based on a 12-week period of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were canceled or postponed in 2020. However, going forward, after the relaxation of lockdown restrictions, the market is expected to experience a spur.

Furthermore, the major factor attributing to the growth of the market is the increasing preference for minimally invasive procedures. Minimally invasive surgeries (MIS) are reported to cause less post-operative pain, and hence, patients receive smaller dosages of painkillers. As there are minimal cuts or stitches involved, the hospital stay is relatively shorter, and patients need not visit the hospital frequently. According to an article titled' Trends in teh Adoption of Robotic Surgery for common surgical procedures' published on JAMA Network in January 2020, with 169,404 patients in 73 hospitals, the use of robotic surgery for all general surgery procedures increased to 15.1% . Hospitals that launched robotic surgery programs had a broad and immediate increase in the use of robotic surgery, which was associated with a decrease in traditional laparoscopic minimally invasive surgery.

The technological advancements in the field of surgical staplers are another major factor driving the growth of the market studied. In the last few years, there have been revolutionary advances in the development of skin staplers. For Instance, In April 2021, Ethicon, a part of Johsnon and Johnson company launched the powered surgical stapler, theEchelon stapler with gripping surface technology reloads.

However, owing to the increased risk of infections and stringent regulations, the adoption of surgical staplers may be less among the population, and therefore, it is one of the factors expected to impede the overall growth of the market studied.

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 5.2 billion  
Revenue Forecast by 2030 USD 9.3 billion 
Growth rate from 2022 to 2030 CAGR of 7.49%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Technology, Type, Product, Application, End User, Region
Companies Covered

Medtronic PLC, Ethicon (J&J), B. Braun Melsungen AG, ConMed Corporation, 3M Company, Covidien plc, CryoLife Inc., Smith & Nephew (U.K.), Stryker Corporation, Surkon Medical

 

Numerous applications of circular staplers will spur the segment growth

 The circular stapler segment held 31% of the market share in 2020 led by the increase in use of circular staplers in range of applications including general surgery, surgical obesity treatment and various other complicated surgeries. Additionally, the growing acceptance of these staplers in end-to-end, side-to-end, and side-to-side anastomosis will expand the market value.

Increasing automation in healthcare sector across the globe will boost the segment expansion

The powered segment in the surgical staplers market accounted for over USD 2.92 billion in 2020 impelled by numerous benefits offered by these staplers including accurate wound closure, fewer leaks, stability and less compressive force. The increased research and development activities in order to improve the operational capabilities of powered surgical staplers will open new avenues for the industry progression. Also, ease of use and reduced hospitalization cost in comparison to manual staplers will fuel the market growth.

 Rising demand for disposable staplers will positively impact the industry expansion

The disposable segment captured more than USD 2.71 billion in 2020 on account of the increasing usage of disposable staplers in complex chronic surgeries including heart surgeries. Disposable staplers are considered a preferred choice for minor wounds and post-operative wound closure. All such factors will result in increased product demand thereby driving the segment value.

The gynaecology surgery segment valued at USD 612 million in 2020. The increasing proportion of caesarean deliveries in comparison to normal deliveries will propel the market expansion. According to the Centers for Disease Control and Prevention (CDC), in 2019, around 1.2 million caesarean deliveries were conducted in the U.S. Thus, the rising proportion of caesarean deliveries will result in increased adoption of surgical staplers.

Key Market Trends

The Orthopedic Surgery Segment Holds a Major Share in the Market

Orthopedic surgery is a specialty that deals with acute injuries, congenital and acquired disorders, and chronic arthritic or overuse conditions of the bones, joints, and their associated soft tissues, including ligaments, nerves, and muscles.

The burden of OA (osteoarthritis) is expected to increase across the world in the coming decades. The article titled ' Statistics of Osteoarthritis in the United Kingdom ' published in March 2021 mentioned that 10% of adults in the United Kingdom have been clinically diagnosed with Osteoarthritis. Also, the above-mentioned source also published that there is a peaked occurrence of Osteoarthritis between the ages of 75-79 years at which time the incidence has reached 35% among men and 47% among women.

Furthermore, market players are focusing on continuous developments and launches of novel products to gain a competitive edge in the market. For instance, in August 2021 Fuse Medical Inc launched the first implantations of the Fuse Orbutum Compression Staple. This was the Latest addition to Fuse's Comprehensive orthopedic portfolio of internal fixation devices for upper and lower extremities.

However, there will be a short-term negative impact on the segment growth, as there will be a temporary halt on surgical procedures globally due to the COVID-19 pandemic. According to the research conducted by the CovidSurg Collaborative in May 2020, a research network, orthopedic procedures will be canceled the most frequently, with 6.3 million orthopedic surgeries canceled worldwide over a 12-week period.

North America Dominates the Market and is Expected to do the Same in the Forecast Period

North America is expected to dominate the overall market throughout the forecast period. This is due to the large obese population and an increasing number of various surgical procedures. Various applications of surgical staplers include the areas of gynecology, abdominal surgeries, cardiothoracic and amputations, etc. The article titled 'Fingertip injuries and Amputations: A review of the literature ' published in May 2020 mentioned that as many as 45,000 finger amputations are performed in the United States per year with an incidence rate of 7.5 per 100,000 people. Such amputations are expected to drive the demand for a surgical stapler in the United States.

Additionally, product approvals are also significant driving factors that are propelling the segment growth in the region. ?In December 2021, Intuitive received Food and Drug Administration clearance for an 8mm Sureform 30 curved-Tip Stapler which is a robotic stapler with 120-degree articulation and Smartfire technology.

Also, the increasing incidence of disorders such as osteoarthritis in the United States also expected to increase the demand for surgical stapler market. According to the Centers for Disease Control and Prevention report in 2021 , in the United States, 24% of all adults, or 58.5 million people have arthritis. 

Recent Development

  • In October 2021, Medtronic plc announced that it has received CE (Conformité Européenne) Mark for the Hugo™ robotic-assisted surgery (RAS) system, authorizing the sale of the system in Europe. CE Mark approval is for urologic and gynecologic procedures, which make up about half of all robotic procedures performed today.
  • In October 2020, 3M announced the availability of PREVENA RESTOR AXIO•FORM™ Incision Management System, designed to manage post-operative incisions, as well as the surrounding soft tissue envelope, following the orthopedic surgical repair of lower extremity fractures.

Key Players

  • Medtronic PLC
  • Ethicon (J&J)
  • B. Braun Melsungen AG
  • ConMed Corporation
  • 3M Company
  • Covidien plc
  • CryoLife Inc.
  • Smith & Nephew (U.K.)
  • Stryker Corporation
  • Surkon Medical

Segments covered in the report:

By Technology

  • Manual
  • Powered

By Type

  • Disposable
  • Reusable

By Product

  • Linear staplers
  • Circular staplers
  • Skin staplers
  • Endoscopic staplers
  • Others

By Application

  • Abdominal & Pelvic Surgery
  • General Surgery
  • Cardiac and Thoracic Surgery
  • Orthopaedic Surgery
  • Other Surgical Application

By End User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs) and Clinics

By Region

  • North America
  • Europe
  • The Asia Pacific
  • Rest of the World

Report Content

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates & working

1.3    Forecast calculations

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Surgical staplers industry 3600 synopsis, 2017 - 2030 (USD Million)

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Technology trends

2.1.4    Usability trends

2.1.5    Surgery trends

2.1.6    Regional trends

Chapter 3   Surgical Staplers Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 - 2030 (USD Million)

3.3    Industry impact factors

3.3.1    Growth drivers

3.3.1.1    Increase in number of surgical procedures in North America

3.3.1.2    Rising adoption of staplers over sutures in developing regions of Latin America

3.3.1.3    Technological advancements in surgical staplers

3.3.2    Industry pitfalls & challenges

3.3.2.1    Adverse events and product issues associated with surgical staplers

3.3.2.2    Traditional wound closure practices in developing countries of Asia Pacific

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By technology

3.4.3    By usability

3.4.4    By surgery

3.5    COVID-19 impact analysis

3.6    Regulatory landscape

3.6.1    U.S.

3.6.2    Europe

3.7    Porter’s analysis

3.8    Competitive landscape, 2020

3.8.1    Competitive matrix analysis, 2020

3.9    PESTEL analysis

Chapter 4   Surgical Staplers Market, By Product

4.1    Key segment trends

4.2    Linear staplers

4.2.1    Market size, by region, 2017 - 2030 (USD Million)

4.3    Circular staplers

4.3.1    Market size, by region, 2017 - 2030 (USD Million)

4.4    Skin staplers

4.4.1    Market size, by region, 2017 - 2030 (USD Million)

4.5    Endoscopic staplers

4.5.1    Market size, by region, 2017 - 2030 (USD Million)

4.6    Others

4.6.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 5   Surgical Staplers Market, By Technology

5.1    Key segment trends

5.2    Manual

5.2.1    Market size, by region, 2017 - 2030 (USD Million)

5.3    Powered

5.3.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 6   Surgical Staplers Market, By Usability

6.1    Key segment trends

6.2    Reusable

6.2.1    Market size, by region, 2017 - 2030 (USD Million)

6.3    Disposable

6.3.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 7   Surgical Staplers Market, By Surgery

7.1    Key segment trends

7.2    Gynaecology surgery

7.2.1    Market size, by region, 2017 - 2030 (USD Million)

7.3    Cardiac surgery

7.3.1    Market size, by region, 2017 - 2030 (USD Million)

7.4    Bariatric surgery

7.4.1    Market size, by region, 2017 - 2030 (USD Million)

7.5    Colorectal surgery

7.5.1    Market size, by region, 2017 - 2030 (USD Million)

7.6    Others

7.6.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 8   Surgical Staplers Market, By Region

8.1    Key segment trends

8.2    North America

8.2.1    Market size, by country, 2017 - 2030 (USD Million)

8.2.2    Market size, by product, 2017 - 2030 (USD Million)

8.2.3    Market size, by technology, 2017 - 2030 (USD Million)

8.2.4    Market size, by usability, 2017 - 2030 (USD Million)

8.2.5    Market size, by surgery, 2017 - 2030 (USD Million)

8.2.6    U.S.

8.2.6.1    Market size, by product, 2017 - 2030 (USD Million)

8.2.6.2    Market size, by technology, 2017 - 2030 (USD Million)

8.2.6.3    Market size, by usability, 2017 - 2030 (USD Million)

8.2.6.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.2.7    Canada

8.2.7.1    Market size, by product, 2017 - 2030 (USD Million)

8.2.7.2    Market size, by technology, 2017 - 2030 (USD Million)

8.2.7.3    Market size, by usability, 2017 - 2030 (USD Million)

8.2.7.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.3    Europe

8.3.1    Market size, by country, 2017 - 2030 (USD Million)

8.3.2    Market size, by product, 2017 - 2030 (USD Million)

8.3.3    Market size, by technology, 2017 - 2030 (USD Million)

8.3.4    Market size, by usability, 2017 - 2030 (USD Million)

8.3.5    Market size, by surgery, 2017 - 2030 (USD Million)

8.3.6    Germany

8.3.6.1    Market size, by product, 2017 - 2030 (USD Million)

8.3.6.2    Market size, by technology, 2017 - 2030 (USD Million)

8.3.6.3    Market size, by usability, 2017 - 2030 (USD Million)

8.3.6.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.3.7    UK

8.3.7.1    Market size, by product, 2017 - 2030 (USD Million)

8.3.7.2    Market size, by technology, 2017 - 2030 (USD Million)

8.3.7.3    Market size, by usability, 2017 - 2030 (USD Million)

8.3.7.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.3.8    France

8.3.8.1    Market size, by product, 2017 - 2030 (USD Million)

8.3.8.2    Market size, by technology, 2017 - 2030 (USD Million)

8.3.8.3    Market size, by usability, 2017 - 2030 (USD Million)

8.3.8.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.3.9    Spain

8.3.9.1    Market size, by product, 2017 - 2030 (USD Million)

8.3.9.2    Market size, by technology, 2017 - 2030 (USD Million)

8.3.9.3    Market size, by usability, 2017 - 2030 (USD Million)

8.3.9.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.3.10    Italy

8.3.10.1    Market size, by product, 2017 - 2030 (USD Million)

8.3.10.2    Market size, by technology, 2017 - 2030 (USD Million)

8.3.10.3    Market size, by usability, 2017 - 2030 (USD Million)

8.3.10.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.4    Asia Pacific

8.4.1    Market size, by country, 2017 - 2030 (USD Million)

8.4.2    Market size, by product, 2017 - 2030 (USD Million)

8.4.3    Market size, by technology, 2017 - 2030 (USD Million)

8.4.4    Market size, by usability, 2017 - 2030 (USD Million)

8.4.5    Market size, by surgery, 2017 - 2030 (USD Million)

8.4.6    Japan

8.4.6.1    Market size, by product, 2017 - 2030 (USD Million)

8.4.6.2    Market size, by technology, 2017 - 2030 (USD Million)

8.4.6.3    Market size, by usability, 2017 - 2030 (USD Million)

8.4.6.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.4.7    China

8.4.7.1    Market size, by product, 2017 - 2030 (USD Million)

8.4.7.2    Market size, by technology, 2017 - 2030 (USD Million)

8.4.7.3    Market size, by usability, 2017 - 2030 (USD Million)

8.4.7.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.4.8    India

8.4.8.1    Market size, by product, 2017 - 2030 (USD Million)

8.4.8.2    Market size, by technology, 2017 - 2030 (USD Million)

8.4.8.3    Market size, by usability, 2017 - 2030 (USD Million)

8.4.8.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.4.9    Australia

8.4.9.1    Market size, by product, 2017 - 2030 (USD Million)

8.4.9.2    Market size, by technology, 2017 - 2030 (USD Million)

8.4.9.3    Market size, by usability, 2017 - 2030 (USD Million)

8.4.9.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.5    Latin America

8.5.1    Market size, by country, 2017 - 2030 (USD Million)

8.5.2    Market size, by product, 2017 - 2030 (USD Million)

8.5.3    Market size, by technology, 2017 - 2030 (USD Million)

8.5.4    Market size, by usability, 2017 - 2030 (USD Million)

8.5.5    Market size, by surgery, 2017 - 2030 (USD Million)

8.5.6    Brazil

8.5.6.1    Market size, by product, 2017 - 2030 (USD Million)

8.5.6.2    Market size, by technology, 2017 - 2030 (USD Million)

8.5.6.3    Market size, by usability, 2017 - 2030 (USD Million)

8.5.6.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.5.7    Mexico

8.5.7.1    Market size, by product, 2017 - 2030 (USD Million)

8.5.7.2    Market size, by technology, 2017 - 2030 (USD Million)

8.5.7.3    Market size, by usability, 2017 - 2030 (USD Million)

8.5.7.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.5.8    Argentina

8.5.8.1    Market size, by product, 2017 - 2030 (USD Million)

8.5.8.2    Market size, by technology, 2017 - 2030 (USD Million)

8.5.8.3    Market size, by usability, 2017 - 2030 (USD Million)

8.5.8.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.6    Middle East and Africa

8.6.1    Market size, by country, 2017 - 2030 (USD Million)

8.6.2    Market size, by product, 2017 - 2030 (USD Million)

8.6.3    Market size, by technology, 2017 - 2030 (USD Million)

8.6.4    Market size, by usability, 2017 - 2030 (USD Million)

8.6.5    Market size, by surgery, 2017 - 2030 (USD Million)

8.6.6    South Africa

8.6.6.1    Market size, by product, 2017 - 2030 (USD Million)

8.6.6.2    Market size, by usability, 2017 - 2030 (USD Million)

8.6.6.3    Market size, by surgery, 2017 - 2030 (USD Million)

8.6.7    Saudi Arabia

8.6.7.1    Market size, by product, 2017 - 2030 (USD Million)

8.6.7.2    Market size, by technology, 2017 - 2030 (USD Million)

8.6.7.3    Market size, by usability, 2017 - 2030 (USD Million)

8.6.7.4    Market size, by surgery, 2017 - 2030 (USD Million)

8.6.8    UAE

8.6.8.1    Market size, by product, 2017 - 2030 (USD Million)

8.6.8.2    Market size, by technology, 2017 - 2030 (USD Million)

8.6.8.3    Market size, by usability, 2017 - 2030 (USD Million)

8.6.8.4    Market size, by surgery, 2017 - 2030 (USD Million)

Chapter 9   Company Profiles

9.1    Competitive dashboard, 2020

9.2    3M

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.2.5    SWOT analysis

9.3    B. Braun Melsungen AG

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    Strategic outlook

9.3.5    SWOT analysis

9.4    CONMED Corporation

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.4.5    SWOT analysis

9.5    Ethicon (Johnson & Johnson)

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.5.5    SWOT analysis

9.6    Frankenman International

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.6.5    SWOT analysis

9.7    Grena

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook

9.7.5    SWOT analysis

9.8    Integra Life Sciences

9.8.1    Business overview

9.8.2    Financial data

9.8.3    Product landscape

9.8.4    Strategic outlook

9.8.5    SWOT analysis

9.9    Intuitive Surgical Inc.

9.9.1    Business overview

9.9.2    Financial data

9.9.3    Product landscape

9.9.4    Strategic outlook

9.9.5    SWOT analysis

9.10    Medtronic

9.10.1    Business overview

9.10.2    Financial data

9.10.3    Product landscape

9.10.4    Strategic outlook

9.10.5    SWOT analysis

9.11    Meril Life Sciences Pvt Ltd.

9.11.1    Business overview

9.11.2    Financial data

9.11.3    Product landscape

9.11.4    Strategic outlook

9.11.5    SWOT analysis

9.12    Purple Surgical

9.12.1    Business overview

9.12.2    Financial data

9.12.3    Product landscape

9.12.4    Strategic outlook

9.12.5    SWOT analysis

9.13    Reach Surgical

9.13.1    Business overview

9.13.2    Financial data

9.13.3    Product landscape

9.13.4    Strategic outlook

9.13.5    SWOT analysis

9.14    Smith & Nephew PLC

9.14.1    Business overview

9.14.2    Financial data

9.14.3    Product landscape

9.14.4    Strategic outlook

9.14.5    SWOT analysis

9.15    Welfare Medical Ltd.

9.15.1    Business overview

9.15.2    Financial data

9.15.3    Product landscape

9.15.4    Strategic outlook

9.15.5    SWOT analysis

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask to Expert